JPRN-UMIN000021494已完成未知
Comparison of lipid lowering effect of anagliptin and miglitol in patients with type 2 diabetes - Comparison of lipid lowering effect of anagliptin and miglitol
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients treated with alpha glucosidase inhibitor, DPP-4 inhibitor, insulin, or glucagon like peptide-1receptor agonist. Patients with sever liver and kidney disfunction. Patients with pregnacy. Patients with history of ileus.
研究者
相似试验
已完成
不适用
The lipid lowering effect of anagliptin in type2 diabetes mellitus with dyslipidemiaType2 diabetes mellitus patients with dyslipidemiaJPRN-UMIN000013682Internal Medicine, Teikyo University School of Medicine40
已完成
不适用
Effect of anagliptin on lipid metabolism in non-diabetic meHyperlipidemiaJPRN-UMIN000011355Yokohama City University Hospital30
已完成
不适用
Effect of anagliptin on lipid profile in type 2 diabetic patients with hyperlipidemiaType 2 diabetesJPRN-UMIN000013878Yokohama City University Hospital30
已完成
不适用
The effect of anagliptin on blood glucose and lipid levels in type 2 diabetes melliusType 2 diabetes mellitusJPRN-UMIN000012533Yokohama City University Medical Center100
已完成
不适用
Comparison of efficacy of anagliptin and alogliptin for lipid profile between type 2 diabetic patientstype 2 diabetes mellitusJPRN-UMIN000018949niversity of Occupational and Environmental Health, Japan, First Department of Internal Medicine, School of Medicine100